Search by Drug Name or NDC
NDC 00006-0473-61 ISENTRESS 25 mg/1 Details
ISENTRESS 25 mg/1
ISENTRESS is a ORAL TABLET, CHEWABLE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Merck Sharp & Dohme LLC. The primary component is RALTEGRAVIR POTASSIUM.
MedlinePlus Drug Summary
Raltegravir is used along with other medications to treat human immunodeficiency virus (HIV) infection in adults and children who weigh at least 4.5 lbs (2 kg). Raltegravir is in a class of medications called HIV integrase inhibitors. It works by decreasing the amount of HIV in the blood. Although raltegravir does not cure HIV, it may decrease your chance of developing acquired immunodeficiency syndrome (AIDS) and HIV-related illnesses such as serious infections or cancer. Taking these medications along with practicing safer sex and making other life-style changes may decrease the risk of transmitting (spreading) the HIV virus to other people.
Related Packages: 00006-0473-61Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Raltegravir
Product Information
| NDC | 00006-0473 |
|---|---|
| Product ID | 0006-0473_6898502e-696b-4ccc-aa35-f00e2f172c39 |
| Associated GPIs | 12103060100510 |
| GCN Sequence Number | 068334 |
| GCN Sequence Number Description | raltegravir potassium TAB CHEW 25 MG ORAL |
| HIC3 | W5U |
| HIC3 Description | ANTIVIRALS,HIV-1 INTEGRASE STRAND TRANSFER INHIBTR |
| GCN | 31097 |
| HICL Sequence Number | 035072 |
| HICL Sequence Number Description | RALTEGRAVIR POTASSIUM |
| Brand/Generic | Brand |
| Proprietary Name | ISENTRESS |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | RALTEGRAVIR |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET, CHEWABLE |
| Route | ORAL |
| Active Ingredient Strength | 25 |
| Active Ingredient Units | mg/1 |
| Substance Name | RALTEGRAVIR POTASSIUM |
| Labeler Name | Merck Sharp & Dohme LLC |
| Pharmaceutical Class | HIV Integrase Inhibitors [MoA], Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor [EPC] |
| DEA Schedule | n/a |
| Marketing Category | NDA |
| Application Number | NDA203045 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00006-0473-61 (00006047361)
| NDC Package Code | 0006-0473-61 |
|---|---|
| Billing NDC | 00006047361 |
| Package | 60 TABLET, CHEWABLE in 1 BOTTLE (0006-0473-61) |
| Marketing Start Date | 2011-12-21 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |